Session Details
[JS09]The novel treatment strategy fused by research both pharmaceutical organic chemistry and pharmaceutics
Fri. Mar 28, 2025 4:45 PM - 6:15 PM JST
Fri. Mar 28, 2025 7:45 AM - 9:15 AM UTC
Fri. Mar 28, 2025 7:45 AM - 9:15 AM UTC
Room 2 (Fukuoka International Congress Center: 501 [5F])
Organizer: Masateru Miyake (Pharmapack), Hiroyuki Kusuhara (Grad. Sch. Pharm., Tokyo Univ.)
[App translation available]
オーガナイザー挨拶:三宅 正晃(ファーマパック)
[JS09-1]Catalysis medicine driven by the merger of organic chemistry and pharmaceutics
○Motomu Kanai1 (1. Grad. Sch. Pharm. Sci., The Univ. of Tokyo)
[JS09-2]Anticancer properties of artemisinin and new therapeutic strategies for intractable cancer
○Tomoka Nakase1 (1. Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University)
[JS09-3]Chemical transformation of medicines to assist the discovery of pharmaceutical research
○Takuya Kumamoto1 (1. Grad. Sch. Biomedical & Health Sciences, Hiroshima Univ.)
[JS09-4]Development of kidney-targeted drug delivery system for medium-sized peptides using serine-modified drug carrier
○Hidemasa Katsumi1 (1. Faculty Pharm., Osaka Ohtani Univ.,)